- Ballantyne GH. Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 1993; 71 (Suppl 12): 4252-66.
- Yoon SS, Tanabe KK. Surgical treatment and other regional treatments for colorectal cancer liver metastases. The Oncolo-gist 1999; 4: 197-208.
- Choti MA, Bulkley GB. Management of hepatic metastases. Liver Transpl Surg 1999; 5: 65-80.
- Scheele J, Stang R, Hofmann-Altendorf A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on natural history. Br J Surg 1990; 77: 1241-6.
- Fong Y, SaIo J. Surgical therapy of hepatic colorectal metas-tasis. Semin Oncol 1999; 26: 514-23.
- Schlag P, Hohenberger P, Herfath C. Resection of liver metastases in colorectal cancer-competitive analysis of treatment results in synchronous versus metachronous metastases. Eur J Surg Oncol 1990; 16: 360-5.
- Scheele J, Stang R, Altendorf-Hofmann A, et al. Resection of colorectal liver metastases. World J Surg 1995; 19: 59-71.
- Nordlinger B, Guiguet M, Vaillant J-C, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Cancer 1996; 77: 1254-62.
- Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15: 938-46.
- Chiappa A, Zbar AP, Biella F, Staudacher C. Survival after repeat hepatic resection for recurrent colorectal metastases. Hepatogastroenterology 1999; 46: 1065-70.
- Imamura H, Kawasaki S, Miyagawa S, Ikegami T, Kitamura H, Shimada R. Aggressive surgical approach to recurrent tumors after hepatectomy for metastatic spread of colorectal cancer to the liver. Surgery 2000; 127: 528-35.
- Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: a planned strategy to treat irre-sectable liver tumours. Ann Surg 2000; 232: 777-85.
- Oldhafer KJ, Lang H, Schutt HJ, et al. Long-term experience after ex situ liver surgery. Surgery 2000; 127: 520-7.
- Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 1991; 110: 726-34.
- Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999; 341: 2039-48.
- Whittaker DK. Mechanisms of tissue destruction following cryosurgery. Ann R Coll Surg Engl 1984; 66: 313-8.
- Morris DL, Horton MD, Dilley AV, et al. Treatment of hepatic metastases by cryotherapy and regional cytotoxic perfusion. Gut 1993; 34: 1158-61.
- Onik GM, Atkinson D, Zemel R, et al. Cryosurgery of the liver. Semin Surg Oncol 1993; 9: 309-17.
- Goldberg SN, Gazelle GS, Dawson SL, et al. Tissue ablation with radiofrequency using multiprobe assays. Acad Radiol 1995; 2: 670-4.
- Solbiati L, Goldberg SN, Tiziana I, et al. Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology 1997; 205: 367-73.
- Livraghi T, Goldberg SN, Monti, et al. Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases. Radiology 1997; 202: 205-10.
- Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radio-frequency ablation of hepatic metastases from col-orectal cancer: long-term results in 117 patients. Radiology 2001; 221: 159-66.
- Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: Long term results of percutaneous ethanol injection. Radiology 1995; 197: 101-8.
- Giovannini M, Seitz JF. Ultrasound-guided percutaneous injection of small liver metastases. Cancer 1994; 73: 294-7.
- Kemeny N, Cohen A, Seiter K, et al. Randomized trial of hepatic arterial floxuridine, mitomycin and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer. J Clin Oncol 1993; 11: 330-5.
- Meta-Analysis Group in Cancer. Reappraisal of hepatic arte-rial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 1996; 88: 252-8.
- Ragnhammar P, Hafström L, Nygren P, et al. A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol 2001; 40: 282-308.
- Douillard JY, Cunningham D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer a multicentre randomised trial. Lancet 2000; 355: 1041-7
- de Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treat-ment in advanced colorectal cancer. J Clin Oncol 2000; 18: 2938-47.
- Levi F, Zidani R, Misset JL. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy. Lancet 1997; 350: 681-6.
- Bismuth H, Adam R, Levi F, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996; 224: 509-22.
- Giachetti S, Itzhaki M, Gruia G, et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with S-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 1999; 10: 663-9.
- Adam R, Avisar E, Ariche A, et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal liver metastases. Ann Surg Oncol 2001; 8: 347-53.
Acta Oncologica
Volume 41, 2002 - Issue 7-8